Valneva SE (XPAR:VLA) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:VLA Valneva SE XPAR:VLA
58 GF Score
Price €2.80
GF Value €2.32
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Valneva SE Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Valneva SE  (XPAR:VLA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Valneva SE Cyclically Adjusted PS Ratio Related Terms


Valneva SE Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Valneva SE's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valneva SE Cyclically Adjusted PS Ratio Chart

Valneva SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.60 3.68 2.65 1.17 2.02

Valneva SE Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 2.73 2.06 1.56 1.25

XPAR:VLA vs VRTX, REGN, MRNA: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, Valneva SE's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valneva SE Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valneva SE's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Valneva SE's Cyclically Adjusted PS Ratio falls into.


XPAR:VLA
58GF Score
Valneva SE XPAR:VLA
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valneva SE Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Valneva SE's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Valneva SE's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.184/123.5000*123.5000
=0.184

Current CPI (Jun. 2026) = 123.5000.

Valneva SE Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.243 100.340 0.299
201612 0.331 100.650 0.406
201703 0.362 101.170 0.442
201706 0.323 101.320 0.394
201709 0.286 101.330 0.349
201712 0.368 101.850 0.446
201803 0.408 102.750 0.490
201806 0.342 103.370 0.409
201809 0.246 103.560 0.293
201812 0.378 103.470 0.451
201903 0.359 103.890 0.427
201906 0.214 104.580 0.253
201909 0.293 104.500 0.346
201912 0.487 104.980 0.573
202003 0.383 104.590 0.452
202006 0.140 104.790 0.165
202009 0.120 104.550 0.142
202012 0.567 104.960 0.667
202103 0.253 105.750 0.295
202106 0.251 106.340 0.292
202109 0.224 106.810 0.259
202112 2.758 107.850 3.158
202203 0.203 110.490 0.227
202206 0.657 112.550 0.721
202209 1.337 112.740 1.465
202212 0.806 114.160 0.872
202303 0.242 116.790 0.256
202306 0.290 117.650 0.304
202309 0.274 118.260 0.286
202312 0.302 118.390 0.315
202403 0.236 119.470 0.244
202406 0.274 120.200 0.282
202409 0.283 119.560 0.292
202412 0.326 119.950 0.336
202503 0.303 120.380 0.311
202506 0.298 121.360 0.303
202509 0.171 120.950 0.175
202512 0.275 120.890 0.281
202603 0.180 122.410 0.182
202606 0.184 123.500 0.184

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Valneva SE (XPAR:VLA) Overvalued in 2026?

Based on GuruFocus' analysis, Valneva SE stock appears to be overvalued. The current stock price of €2.80 is trading 20.7% above its estimated GF Value™ of €2.32. GuruFocus considers Valneva SE to be Modestly Overvalued.

Key valuation signals for XPAR:VLA:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €2.32 vs. price of €2.80 (20.7% above fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the XPAR:VLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Valneva SE Business Description

Address 12 ter Quai Perrache, Bureaux Convergence, Bat. A, Ilot Saint-Joseph, Lyon, FRA, 69002
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
58GF Score

Get the complete analysis for XPAR:VLA

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.80
Price
€2.32
GF Value